{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:12:02Z","timestamp":1779275522774,"version":"3.51.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:p>\n                    Sepsis is a complex disease with limited therapeutics. We conducted a 2-sample Mendelian randomization (MR) analysis to identify circulating inflammatory proteins as potential drug targets for sepsis. Protein quantitative trait loci (pQTLs) at cis-region for 448 circulating inflammatory proteins were obtained from the UK biobank pharma proteomics project (UKB-PPP) (N\u2005=\u200554219), and summary-level genetic associations with sepsis were extracted from the FinnGen cohort (12,301 cases and 332,343 controls) for the primary MR analysis. The findings were further replicated using alternative cis-pQTL (Fenland, N\u2005=\u200510708) and sepsis genome-wide association study data (UK Biobank, 2811 cases and 406,150 controls). Multiple sensitivity analyses including summary-data-based MR (SMR), the HEIDI test, colocalization, and phenome-wide scanning were performed to verify the causality of the identified proteins. Moreover, protein\u2013protein interaction analysis was performed to examine the interactions between identified proteins and current drug targets in clinical trials. With the adjusted\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    -value\u2005&lt;.05, 1-SD increase in genetically determined APOE (apolipoprotein E) was associated with increased risk of sepsis (OR\u2005=\u20051.07, 95%CI\u2005=\u20051.04\u20131.11,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u20055.36\u2009\u00d7\u200910\n                    <jats:sup>\u22125<\/jats:sup>\n                    ). The findings were consistent in the validation analyses. Multi-SNPs SMR analysis (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u20051.42\u2009\u00d7\u200910\n                    <jats:sup>\u22123<\/jats:sup>\n                    ), HEIDI test (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.53), and colocalization analysis (PP4\u2005=\u20050.95) further supported the causality of APOE. Protein\u2013protein interaction analysis suggested that APOE was interacted with multiple drug targets tested in the clinical trials for sepsis. This integrative analysis combing the pQTL and genome-wide association study data identified APOE as a promising drug target for sepsis. Further experimental studies were warranted to explore the details of the underlying biological mechanisms and feasibility of drug development.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045444","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:01:41Z","timestamp":1763571701000},"page":"e45444","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Identification of circulating inflammatory proteins as potential drug targets for sepsis through Mendelian randomization and colocalization analyses"],"prefix":"10.1097","volume":"104","author":[{"given":"Fang","family":"Wan","sequence":"first","affiliation":[{"name":"Emergency Department, Wuxi No.2 People\u2019s Hospital, Jiangnan University Medical Center, Wuxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, JiangYuan Hospital Affiliated to Jiangsu Institute of Nuclear Medicine, Wuxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1705-8317","authenticated-orcid":false,"given":"Jichun","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Affiliated Hospital of Jiangnan University,Wuxi, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s12325-017-0622-8","article-title":"Sepsis: a review of advances in management.","volume":"34","author":"Rello","year":"2017","journal-title":"Adv Ther"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"104363","DOI":"10.1016\/j.ebiom.2022.104363","article-title":"Immunopathophysiology of human sepsis.","volume":"86","author":"Wiersinga","year":"2022","journal-title":"EBioMedicine"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/imj.14199","article-title":"Sepsis and septic shock: current approaches to management.","volume":"49","author":"Thompson","year":"2019","journal-title":"Intern Med J"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock.","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","article-title":"Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.","volume":"52","author":"Zheng","year":"2020","journal-title":"Nat Genet"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"e24142","DOI":"10.1002\/jcla.24142","article-title":"Identification of novel biomarkers for sepsis diagnosis via serum proteomic analysis using iTRAQ-2D-LC-MS\/MS.","volume":"36","author":"Li","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"R7-20260520","doi-asserted-by":"crossref","first-page":"e0278708","DOI":"10.1371\/journal.pone.0278708","article-title":"Characterization of a proteomic profile associated with organ dysfunction and mortality of sepsis and septic shock.","volume":"17","author":"Ruiz-Sanmart\u00edn","year":"2022","journal-title":"PLoS One"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"R9-20260520","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and Mendelian randomization: a review.","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"e1006944","DOI":"10.1371\/journal.pgen.1006944","article-title":"Genetic epidemiology and Mendelian randomization for informing disease therapeutics: conceptual and methodological challenges.","volume":"13","author":"Paternoster","year":"2017","journal-title":"PLoS Genet"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank.","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"104494","DOI":"10.1016\/j.ebiom.2023.104494","article-title":"Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.","volume":"89","author":"Chen","year":"2023","journal-title":"EBioMedicine"},{"key":"R13-20260520","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1093\/brain\/awad070","article-title":"Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.","volume":"146","author":"Lin","year":"2023","journal-title":"Brain"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"104432","DOI":"10.1016\/j.ebiom.2022.104432","article-title":"Mitochondrial related genome-wide Mendelian randomization identifies putatively causal genes for multiple cancer types.","volume":"88","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"eabj1541","DOI":"10.1126\/science.abj1541","article-title":"Mapping the proteo-genomic convergence of human diseases.","volume":"374","author":"Pietzner","year":"2021","journal-title":"Science"},{"key":"R16-20260520","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R17-20260520","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife"},{"key":"R19-20260520","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R20-20260520","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41467-018-03371-0","article-title":"Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits.","volume":"9","author":"Wu","year":"2018","journal-title":"Nat Commun"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41588-019-0404-0","article-title":"Abundant associations with gene expression complicate GWAS follow-up.","volume":"51","author":"Liu","year":"2019","journal-title":"Nat Genet"},{"key":"R22-20260520","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","article-title":"PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations.","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest.","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrg2969","article-title":"From expression QTLs to personalized transcriptomics.","volume":"12","author":"Montgomery","year":"2011","journal-title":"Nat Rev Genet"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"720874","DOI":"10.3389\/fgene.2021.720874","article-title":"No casual relationship between T2DM and the risk of infectious diseases: a two-sample Mendelian randomization study.","volume":"12","author":"Wang","year":"2021","journal-title":"Front Genet"},{"key":"R26-20260520","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3233\/JAD-230954","article-title":"Causal association between sepsis and neurodegenerative diseases: a bidirectional two-sample Mendelian randomization study.","volume":"97","author":"Zeng","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"R27-20260520","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","article-title":"Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases.","volume":"72 Pt A","author":"Huang","year":"2014","journal-title":"Neurobiol Dis"},{"key":"R28-20260520","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.omtn.2023.07.031","article-title":"Apolipoprotein E and viral infection: risks and mechanisms.","volume":"33","author":"Chen","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"R29-20260520","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.amjsurg.2009.10.017","article-title":"An expanding role for apolipoprotein E in sepsis and inflammation.","volume":"200","author":"Chuang","year":"2010","journal-title":"Am J Surg"},{"key":"R30-20260520","doi-asserted-by":"crossref","first-page":"15735","DOI":"10.1038\/s41598-020-72616-0","article-title":"Presence of the apolipoprotein E-\u03b54 allele is associated with an increased risk of sepsis progression.","volume":"10","author":"Shao","year":"2020","journal-title":"Sci Rep"},{"key":"R31-20260520","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.4049\/jimmunol.181.2.1399","article-title":"Apolipoprotein E-mediated immune regulation in sepsis.","volume":"181","author":"Kattan","year":"2008","journal-title":"J Immunol"},{"key":"R32-20260520","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40263-016-0361-4","article-title":"Apolipoprotein E as a therapeutic target in Alzheimer\u2019s disease: a review of basic research and clinical evidence.","volume":"30","author":"Yamazaki","year":"2016","journal-title":"CNS Drugs"},{"key":"R33-20260520","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-2600(23)00158-3","article-title":"Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial.","volume":"11","author":"Fran\u00e7ois","year":"2023","journal-title":"Lancet Respir Med"},{"key":"R34-20260520","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3314","article-title":"The support of human genetic evidence for approved drug indications.","volume":"47","author":"Nelson","year":"2015","journal-title":"Nat Genet"},{"key":"R35-20260520","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1111\/bph.12829","article-title":"Therapeutic interventions in sepsis: current and anticipated pharmacological agents.","volume":"171","author":"Shukla","year":"2014","journal-title":"Br J Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:03:38Z","timestamp":1779275018000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":35,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045444","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2025-08-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}